ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0N4A Oasmia Pharmaceutical Ab

5.2065
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20172018201920202020202120222023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Revenue 390k4.77M2.22M201.95M2.76M68.48M4.68M9.5M
Operating Income -140.68M-103.24M-151.33M-30.41M-131.7M-128.84M-364.35M-132.2M
Pre Tax Income -160.24M-118.01M-169.06M-43.36M-140.27M-132.72M-365.72M-128.74M
Net Income -160.24M-118.01M-201.89M-10.53M-140.27M-132.72M-365.72M-128.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.271-0.669-0.898-0.023-0.313-0.296-0.68-0.239
EBIT -140.68M-103.24M-151.33M-30.41M-131.7M-128.84M-364.35M-132.2M
EBITDA -136.18M-98.45M-119.74M-10.38M-102.77M-99.97M-99.19M-74.82M

Your Recent History

Delayed Upgrade Clock